Merck & Co
Merck & Co price
About Merck & Co
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
- Stock ticker
- MRK
- Company
- Merck & Co., Inc.
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 125131
- Launch date
- Jan 13, 1978
- Listed exchange
- NYSE
Financials
Summary: MRK reported Revenue of 16.61B (+5.07%), beating expectations; EPS of -0.13 (-106.10%), beating expectations.
Dividends
Merck & Co conversion tables
 |  |
|---|---|
| 0.5 MRK | 72.09 USD |
| 1 MRK | 144.19 USD |
| 5 MRK | 720.95 USD |
| 10 MRK | 1,441.9 USD |
| |
|---|---|
| 0.5 USD | 0.0034676 MRK |
| 1 USD | 0.0069353 MRK |
| 5 USD | 0.034676 MRK |
| 10 USD | 0.069353 MRK |
More to explore
FAQ
MRK is trading at $144.19, -0.08% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MRK stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MRK is currently trading at $144.19, -0.08% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MRK price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MRK's P/E ratio is currently 115.44 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MRK; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MRK's historical range and other companies in the Healthcare sector.
Merck & Co., Inc.'s market cap is currently 356.4B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.